REFINE | Phase II multi-arm basket protocol testing reduced intensity immunotherapy across different cancers |
RAMPART | Phase III MAMS platform trial of adjuvant therapy in resected intermediate/high risk renal cell cancer |
Add-Aspirin | Phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours |
STAMPEDE | Phase III MAMS RCT evaluating Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy |
For the API
|
For the PI
For Study Team/CTU
For the Patient
|
The MRC CTU (UCL) will be running a monthly webinar series on the last Thursday of every month (6-7pm via TEAMS) for all APIs affiliated with a trial at the MRC CTU (UCL).
There will be a range of expert speakers including statisticians, health economists and experienced investigators.
Please see the timetable for the upcoming webinar series below:
Thursday 31st March | Trial design including novel trial designs and non-inferiority trials | Matthew Nankivell Senior Statistician MRC CTU (UCL) |
Thursday 28th April | Pharmacovigilance and Safety | Hannah Rush Clinical Fellow MRC CTU (UCL) |
Thursday 26th May | An Introduction to Health Economics | Caroline Clarke Health Economist (UCL) |
Thursday 30th June | Understanding statistics: Hazard ratios, sample size, power calculations | Matthew Nankivell Senior Statistician MRC CTU (UCL) |
Thursday 28th July | How to be a good Principal Investigator | Duncan Gilbert Clinical Lecturer MRC CTU (UCL) |
These sessions will be recorded and will be available here.
Go to the NIHR Associate PI Scheme Website: www.NIHR.ac.uk/AssociatePIScheme.
To register a study, complete the Associate PI Scheme Study Registration Form.
To register to be an Associate PI, complete the Associate PI Scheme Applicant Registration Form.